Home » Stocks » Chiasma

Chiasma, Inc. (CHMA)

Stock Price: $4.65 USD 0.28 (6.29%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed
After-hours: $4.62 -0.03 (-0.54%) Aug 3, 5:25 PM

Stock Price Chart

Key Info

Market Cap 254.38M
Revenue (ttm) n/a
Net Income (ttm) -42.96M
Shares Out 42.27M
EPS (ttm) -1.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $4.65
Previous Close $4.37
Change ($) 0.28
Change (%) 6.29%
Day's Open 4.41
Day's Range 4.38 - 4.76
Day's Volume 509,311
52-Week Range 2.88 - 7.75

More Stats

Market Cap 254.38M
Enterprise Value 175.12M
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 42.27M
Float 35.40M
EPS (basic) -1.1
EPS (diluted) -1.11
FCF / Share -0.95
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.17M
Short Ratio 1.27
Short % of Float 5.04%
Beta 1.49
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.57
Revenue n/a
Operating Income -44.37M
Net Income -42.96M
Free Cash Flow -40.23M
Net Cash 79.26M
Net Cash / Share 1.45
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -39.17%
ROE -87.87%
ROIC -85.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(249.84% upside)
Current: $4.65
Target: 16.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth------82%-
Gross Profit-----13.1773.13
Operating Income-37.58-32.34-28.13-61.31-35.45-1.8338.61
Net Income-36.32-31.26-26.83-61.11-35.91-2.0136.18
Shares Outstanding34.2024.4024.3724.3211.150.040.04
Earnings Per Share-1.06-1.28-1.10-2.51-3.25-66.21-125.29
Operating Cash Flow-35.01-24.09-24.42-51.96-33.30-6.4046.19
Capital Expenditures-0.31-0.01-0.02-2.83-0.260.08-0.01
Free Cash Flow-35.32-24.10-24.45-54.79-33.56-6.3246.18
Cash & Equivalents92.3841.6666.9492.9814940.1612.85
Net Cash / Debt92.3841.6666.9492.9814940.1612.85
Book Value85.7734.1262.4785.73143-72.02-70.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Chiasma, Inc.
Country United States
Employees 49
CEO Raj Kannan

Stock Information

Ticker Symbol CHMA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CHMA
IPO Date July 16, 2015


Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.